ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
BGIN
BGIN BLOCKCHAIN Ltd
There isn't enough reported data to score BGIN yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BGIN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Strong |
BGIN's balance sheet is currently strong, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
BGIN PE Valuation
BGIN has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
BGIN Forward outlook
There aren't enough analyst estimates for BGIN to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
BGIN has the stronger earnings trend. Trailing diluted EPS is down 273% for ASTS versus BGIN down 203%.
BGIN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$1.62 | -370% |
| Q4 2024 | $0.60 | -53% |
| Q3 2024 | $1.23 | +95% |
| Q2 2024 | $1.86 | +$1.88 |
| Q1 2024 | $1.58 | +$1.58 |
| Q4 2023 | $1.29 | +4200% |
| Q3 2023 | $0.63 | +950% |
| Q2 2023 | -$0.02 | -125% |
BGIN has swung to a loss: it lost $1.62 per share over the past year, after a profit the year before.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the stronger quarterly revenue trend. Revenue is up 187% for ASTS versus down 6.7% for BGIN.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
BGIN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $67.4M | -15% |
| Q4 2024 | $78.9M | -36% |
| Q3 2024 | $78.9M | -36% |
| Q2 2024 | $72.2M | +1418% |
| Q1 2024 | $72.2M | +1418% |
| Q4 2023 | $123.9M | +6480% |
| Q3 2023 | $123.9M | +6480% |
| Q2 2023 | $4.8M | -16% |
BGIN's revenue has slid since its 2023 peak: $67M last quarter, down 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -261% | -314 points |
| Q4 2024 | 3.1% | -66 points |
| Q3 2024 | 3.1% | -66 points |
| Q2 2024 | 53% | +27 points |
| Q1 2024 | 53% | +27 points |
| Q4 2023 | 69% | +234 points |
| Q3 2023 | 69% | +234 points |
| Q2 2023 | 26% | -24 points |
BGIN's operating margin was −261% last quarter, down 314 points from the same quarter a year ago, near the bottom of its range since 2021.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
BGIN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$171.1M | -$111.1M |
BGIN and ASTS do not have enough comparable growth data to identify a winner.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
BGIN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +1.2M shares |
| 1 year | +1.2% | +1.2M shares |
| 3 years | +52% | +37.2M shares |
BGIN has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BGIN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2024 | -1.1x | Net Cash |
| Q3 2024 | -0.6x | Net Cash |
| Q2 2024 | -0.2x | Net Cash |
BGIN has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
BGIN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.7 | Neutral |
| Stochastic | 26.5 | Neutral |
BGIN's weekly RSI is 56 (neutral) and its Stochastic is 27 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
BGIN PE vs Technology Sector
BGIN has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
BGIN has stronger trend alignment. ASTS is above 1 of 5 weekly averages versus BGIN above 3 of 3.
BGIN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.02 | 37% above |
| 20 week MA | $1.97 | 40% above |
| 50 week MA | $2.56 | 7.8% above |
BGIN is in an uptrend: it's above all three of its weekly moving averages, and 7.8% above its 50-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
BGIN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $4.70 | $2.50 | -47% |
| 2026 YTD | $2.50 | $2.76 | +10% |
BGIN has the edge over ASTS on returns for 2026, with the stronger performance.